These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 21789914)
1. [Effects of calcium antagonists on brain ischemia]. Naumović N; Slankamenac P; Filipović D; Ivetić V; Todorović ST; Bosković K Med Pregl; 2011; 64(5-6):257-61. PubMed ID: 21789914 [TBL] [Abstract][Full Text] [Related]
2. Effects of clinical and laboratory variables at admission and of in-hospital treatment with cardiovascular drugs on short term prognosis of ischemic stroke. The GIFA study. Tuttolomondo A; Di Raimondo D; Di Sciacca R; Pedone C; La Placa S; Arnao V; Pinto A; Licata G Nutr Metab Cardiovasc Dis; 2013 Jul; 23(7):642-9. PubMed ID: 22502765 [TBL] [Abstract][Full Text] [Related]
3. Calcium antagonists for ischemic stroke: a systematic review. Horn J; Limburg M Stroke; 2001 Feb; 32(2):570-6. PubMed ID: 11157199 [TBL] [Abstract][Full Text] [Related]
5. Benefits of the angiotensin II receptor antagonist olmesartan in controlling hypertension and cerebral hemodynamics after stroke. Matsumoto S; Shimodozono M; Miyata R; Kawahira K Hypertens Res; 2009 Nov; 32(11):1015-21. PubMed ID: 19745828 [TBL] [Abstract][Full Text] [Related]
7. CBF decreases after calcium antagonist treatment in acute ischemic stroke. Vorstrup S; Paulson OB; Andersen A Agressologie; 1989 Jun; 30(7):447-9. PubMed ID: 2817242 [TBL] [Abstract][Full Text] [Related]
8. Use of Antihypertensive Drugs and Ischemic Stroke Severity - Is There a Role for Angiotensin-II? Hwong WY; Bots ML; Selvarajah S; Abdul Aziz Z; Sidek NN; Spiering W; Kappelle LJ; Vaartjes I PLoS One; 2016; 11(11):e0166524. PubMed ID: 27846309 [TBL] [Abstract][Full Text] [Related]
9. Amlodipine treatment reduces stroke size in apolipoprotein E-deficient mice. Mogi M; Iwai M; Chen R; Iwanami J; Ide A; Tsukuda K; Yoshii T; Horiuchi M Am J Hypertens; 2006 Nov; 19(11):1144-9. PubMed ID: 17070425 [TBL] [Abstract][Full Text] [Related]
10. Hemodynamic influences of azelnidipine, a novel calcium channel blocker, on cerebral circulation in hypertensive patients with ischemic white matter lesions. Kimura Y; Kitagawa K; Oku N; Kajimoto K; Kato H; Tanaka M; Sakaguchi M; Hougaku H; Sakoda S; Hatazawa J Hypertens Res; 2008 Dec; 31(12):2147-54. PubMed ID: 19139604 [TBL] [Abstract][Full Text] [Related]
11. [Cerebral circulation and calcium antagonists]. Uematsu D; Fukuuchi Y No To Shinkei; 1990 Jan; 42(1):17-31. PubMed ID: 2186763 [No Abstract] [Full Text] [Related]
12. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy]. Govoni S; Trabucchi M; Battaini F; Magnoni MS; Paoletti R Minerva Med; 1986 Jun; 77(24):1053-8. PubMed ID: 3725133 [TBL] [Abstract][Full Text] [Related]
13. Effect of calcium antagonists on the cerebral circulation. Gelmers HJ Am J Cardiol; 1987 Jan; 59(3):173B-176B. PubMed ID: 2433932 [TBL] [Abstract][Full Text] [Related]
14. Calcium-channel blockers: effects on cerebral blood flow and potential uses for acute stroke. Gelmers HJ Am J Cardiol; 1985 Jan; 55(3):144B-148B. PubMed ID: 2578724 [TBL] [Abstract][Full Text] [Related]
15. [Calcium antagonists and cerebrovascular circulation]. De Gregorio C Clin Ter; 1987 Oct; 123(1):41-50. PubMed ID: 2972466 [No Abstract] [Full Text] [Related]
16. Calcium antagonist (PY 108-068) treatment may further decrease flow in ischemic areas in acute stroke. Vorstrup S; Andersen A; Blegvad N; Paulson OB J Cereb Blood Flow Metab; 1986 Apr; 6(2):222-9. PubMed ID: 3485642 [TBL] [Abstract][Full Text] [Related]